JASON MENSAH: Open Payments
NPI 1619137593 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$24,059 in 196 payments from 19 companies in 2025. Trend: 2023 $54,404 · 2024 $35,046 · 2025 $24,059
Honoraria: $12,100Speaker / faculty: $5,750Food & beverage: $3,956Travel & lodging: $2,152Education: $101
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 25 | $14,338 |
| ABBVIE INC. | 23 | $6,045 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $853 |
| Neurocrine BioSciences, Inc. | 18 | $650 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $408 |
| Teva Pharmaceuticals USA, Inc. | 20 | $390 |
| Otsuka America Pharmaceutical, Inc. | 21 | $275 |
| Janssen Pharmaceuticals, Inc | 7 | $209 |
| Corium, LLC | 19 | $195 |
| Lundbeck LLC | 8 | $169 |
Products named: Auvelity, VRAYLAR, INGREZZA, CAPLYTA, REXULTI, Azstarys, AUSTEDO XR, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
